m6A modification involves a diversity of regulators, among which, methyltransferase-like proteins, METTL3 and METTL14, are believed to be the most important m6A initiators and have been proved to perform critical roles in various diseases, especially human malignant tumors [33]. This evidence concerns the gene METTL14 and cancer.